Physical aggression · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Specific behaviour ‐ agitation · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Adverse events: Clinically important effect · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Self harm ‐ frequency of self harm · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Mental state: clinically important change in mental state · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Leaving the study early · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Quality of life: clinically important change in quality of life · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Clinically important change, shown as improved – as defined by individual studies · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · patients with schizophrenia
Group cognitive behavioural therapy for psychosis showed no clear difference in leaving the study early: for any reason – end of treatment compared with standard care (low certainty).
1 finding from 1 review
Clinical response: mean score/change in mental state: mean PANSS total score (high = poor) · patients with schizophrenia
1 finding from 1 review
Days in hospital · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Level of functioning · patients with schizophrenia
1 finding from 1 review
Clinically important change in positive symptoms · schizophrenia spectrum disorders with catatonic symptoms
1 finding from 1 review
Clinically important change in negative symptoms · schizophrenia spectrum disorders with catatonic symptoms
1 finding from 1 review
Catatonia: clinically important change in catatonia symptoms (improved at least 50% on the VAS) · schizophrenia spectrum disorders with catatonic symptoms
1 finding from 1 review
Clinically important adverse drug‐induced movement disorder effects on the central nervous system (EPS, NMS, MC) · schizophrenia spectrum disorders with catatonic symptoms
1 finding from 1 review
Clinically important adverse effects other than central nervous system or EPS · schizophrenia spectrum disorders with catatonic symptoms
1 finding from 1 review
Weight: clinically important change in weight (kg) · people with schizophrenia with antipsychotic‐induced weight gain
1 finding from 1 review